Congratulations on Heba’s new Oncogenesis paper titled “Disruption of STAT5A and NMI signaling axis leads to ISG20-driven metastatic mammary tumors.” As it drew a broad attention to its novel findings.
- Login
- |
- Privacy
- |
- Terms of Use
- |
- © 2024 The University of Alabama at Birmingham
UAB is an Equal Opportunity/Affirmative Action Employer committed to fostering a diverse, equitable and family-friendly environment in which all faculty and staff can excel and achieve work/life balance irrespective of race, national origin, age, genetic or family medical history, gender, faith, gender identity and expression as well as sexual orientation. UAB also encourages applications from individuals with disabilities and veterans.